News
【Important Notice】Replicon Vaccination
The Replicon vaccine (product name: KOSTAIVE intramuscular injection) will become a routine vaccination in Japan on October 1, 2024. This vaccine is a next-generation autologous mRNA vaccine, and its health effects and long-term side effects after vaccination are not yet clear. 【Our Studio’s Policy】 We are temporarily unable to accept visitors who have received the […]